PRESENTATION

Q3 2021 — Presentation

Q3 2021PDF · 34 pages3.8 MB
HSBC Holdings plc 3Q21 Results
Presentation to Investors and Analysts

-- 1 of 34 --

3Q21 results 	Appendix
Our purpose, values and ambition support the execution of our strategy
1
Opening up a world of opportunityOur purpose
 We get it done	 We value difference 	 We succeed together 	 We take responsibility	Our values
Our strategy
To be the preferred international financial partner for our clients	Our ambition
Focus on our strengths 	Digitise at scale 	Energise for growth 	Transition to net zero

-- 2 of 34 --

3Q21 results 	Appendix
3Q21 highlights
2
2 	Execution of strategy continues at pace
1 Reported PBT of $5.4bn up 76% vs. 3Q20; adjusted PBT of $6.0bn up 36% vs. 3Q20,
primarily due to net ECL release of $0.7bn
4 	Liquidity remains strong; CET1 ratio1 of 15.9%; share buyback of $2bn announced
A reconciliation of reported results to adjusted results can be found on slide 16, the remainder of the presentation unless otherwise stated, is presented on an adjusted basis
Figures throughout this presentation may be subject to rounding adjustments and therefore may not sum precisely to totals given in charts, tables or commentary
3 NII stabilising; strong reported fee growth, up 11% vs. 3Q20; good growth in Asia revenue
despite adverse insurance market impacts; good profit contribution from all regions

-- 3 of 34 --

3Q21 results 	Appendix
$bn 	3Q21 	2Q21 	Δ
Customer loans 	1,040 	1,045 	(1)%
Customer deposits 	1,688 	1,647 	2 %
Reported RWAs 	839 	862 	(3)%
CET1 ratio, % 	15.9 	15.6 	0.3ppt
TNAV per share, $ 	7.81 	7.81 	—
$m 	3Q21 	3Q20 	Δ
NII 	6,610 	6,646 	(1)%
Non interest income 	5,591 	5,728 	(2)%
Revenue 	12,201 	12,374 	(1)%
ECL 	659 	(823) 	>100%
Costs 	(7,585) 	(7,612) 	0 %
Associates 	721 	459 	57 %
Adjusted PBT 	5,996 	4,398 	36 %
Significant items and FX translation 	(593) 	(1,324) 	55 %
Reported PBT 	5,403 	3,074 	76 %
Profit attributable to ordinary shareholders 	3,543 	1,359 	>100%
Reported EPS, $ 	0.18 	0.07 	$0.11
Impact of sig items on reported EPS, $ 	(0.02) 	(0.05) 	$0.03
Reported RoTE2 (YTD, annualised), % 	9.1 	3.5 	5.6ppt
3Q21 results summary
3
 	Adjusted PBT of $6.0bn up $1.6bn (36%) vs. 3Q20,
primarily due to a net ECL release of $0.7bn vs. $0.8bn
charge in 3Q20
 	Net interest income stable vs. 3Q20, with the global
interest rate outlook improving
 	Non-interest income down 2% vs. 3Q20, primarily due
to the impact of certain volatile items; strong fee income
growth of $0.3bn (10%) vs. 3Q20 across all businesses 3
 	Net ECL release of $0.7bn reflecting continued stability in
economic conditions and better than expected levels of
credit performance
 	Costs of $7.6bn stable vs. 3Q20, with continued
investment and increased tech spend offset by cost saves
and lower performance related pay accrual
 	Associate income of $0.7bn up $0.3bn (57%) vs.
3Q20, primarily due to higher profits from BoCom
 	Lending down $6bn vs. 2Q21, including the repayment of
$14bn of short-term IPO loans and mortgage growth of
$7bn
 	TNAV per share of $7.81, with profits offsetting dividends
paid and adverse FX movements

-- 4 of 34 --

3Q21 results 	Appendix
Business revenue growth drivers
4
Q3	Q1 	Q2 	Q3	Q4
64.4
Q2	Q1
2021	2020
2020 quarterly average: $34.5bn
WPB
YTD global WPB new-to-bank Premier
customers, ‘000s
9M20 	9M21
260
211
23%
CMB & GBM
 Encouraging trends in global trade visible; 3Q21
trade balances of $79bn up $3bn (4%) QoQ and up
$13bn (20%) YoY, with share gains in key markets:
 Hong Kong trade market share up 2.2ppt to
18.8%7
 Singapore trade market share up 1.9ppt to 12.9%8
 GBM revenue stabilising, comparing well against
strong 2020 performance
 3Q21 equities revenue of $0.3bn up $0.1bn (49%)
YoY
 3Q21 Securities Services Assets Under Custody up
23% YoY
 3Q21 GBM RWAs decreased $20bn (7%) to $249bn
YoY, with only a $105m (3%) decrease in revenue*
* Including adverse XVAs of $84m
** Includes renewal and refinancing activity. Note, clients may elect not to draw down on approved limits
 3Q21 Private Bank NNM of $3.9bn, with
$3.1bn in Asia; AMG NNM of $4.3bn, with $1.3bn
in Asia; reported Wealth Balances 4 of $1.6tn, up
10% YoY
 Insurance VNB up 8% QoQ and 59% YoY due to
strong growth in Hong Kong onshore business
 Over 450 Pinnacle Wealth Planners in-force5
 UK YTD gross mortgage market share of
8.6%; stock mortgage market share of 7.4% 6
 Good new to bank customer acquisition e.g. in
Premier
Global CMB value of approved limits**, $bn
Sustainability
 Helped our clients raise c.$170bn YTD
in Green, Social and Sustainable bonds 9 ,
up 58% YoY
 Joint lead manager on £10bn UK Debt
Management Office inaugural green gilt
 Partnership announced with Temasek to
establish sustainable infrastructure debt
financing platform
 Work underway on May 2021 AGM
special resolution on climate
commitments
Geographic performance
 Pivot to Asia: strong revenue trends;
3Q21 revenue up $99m (2%) QoQ
including adverse market impacts of
$331m; up $143m (2%) YoY, including
adverse insurance market impacts of
$194m
 Good UK RFB performance; 3Q21
revenue up 6% YoY and up 2% QoQ;
strong 3Q21 fee growth, fees up 25%
YoY, up 13% QoQ

-- 5 of 34 --

3Q21 results 	Appendix
145
(167)
(31)
(99)
64
38
(47)
72
(81)
33
5
35
(92)
(43)
142	(173)
5
3Q21 adjusted revenue performance
3Q21 revenue 	3Q21 vs. 3Q20 	Revenue by global business, $bn
3.7
3.2
5.6 	5.4
(0.2)
3.5
3Q20
5.7
3.3
(0.1)
2Q21
3.4
(0.2)
3.6
3Q21
12.4 	12.4 	12.2
(1)%
WPB
Corporate Centre
GBM
CMB
o/w XVAs and bid-offer
adjustment: $(89)m
o/w valuation
differences: $(3)m
(3)%
4%
(3)%	
of which: GLCM
Principal Investments
Market impacts
GLCM
GTRF
Credit and Lending
Other
Wealth (excl. Market
impacts)
Other
$5,418m
$3,374m
$3,604m
$(195)m
$12,201m 	(1)%
$2,206m
$88m
$465m
$1,985m
$458m
$896m
$1,520m
$500m
$185m
$(40)m
MSS
WPB
CMB
GBM
Corp. Centre
Group
Includes $(315)m impact of certain items
Banking 	$1,659m
Other 	$(128)m
Personal Banking 	$3,067m

-- 6 of 34 --

3Q21 results 	Appendix
NII stabilisation and fee growth across global businesses
6
92
60	(237)
Corporate
Centre
2Q21 	WPB 	CMB 	GBM
(109)
3Q21
12,395
12,201
Includes $(374)m of
insurance market
impacts
92
(426)
NII	2Q21 	Net fee
income
(374)
Other income 	3Q21
12,395
140
12,201	(52)
Wealth
GTRF
GLCM
MSS
Other
WPB Insurance market impacts
All other income
Adjusted revenue by global business, $m 	Adjusted revenue by income statement line, $m
 	Strong fee growth across businesses; up $140m (4%) vs. 2Q21 and
up $293m (10%) vs. 3Q20
 	Trade balances of $79bn up $3bn (4%) vs. 2Q21, and up $11bn
(17%) vs. 4Q20; 3Q21 GTRF revenue up $68m (11%) vs. 3Q20
 	3Q21 average GLCM deposits of c.$770bn, up c.$20bn vs. 2Q21
and up c.$50bn vs. 3Q20
 	WPB down $237m (4%) vs. 2Q21, including $374m of adverse
insurance market impacts
 	CMB up $92m (3%), from increases in fees and interest income in
Credit & Lending, GTRF and GLCM
 	GBM up $60m (2%), with increased fee income in Securities Services
and Banking

-- 7 of 34 --

3Q21 results 	Appendix
2,159 	2,179 	2,199
122bps
120bps 121bps 120bps 119bps
(1)bp
7
Net interest income and margin
(2)
2Q21 	Asset mix
1
Liabilities and other 	3Q21
120 119
Reported NIM progression, bps
Reported NIM trend
 	3Q21 reported NII up $26m vs. 2Q21;
adjusted NII was up $92m vs. 2Q21, primarily
due to day count
 	3Q21 NIM of 1.19%, down 1bp vs. 2Q21,
due to an adverse change in balance sheet mix
 	NII has stabilised and the global interest rate
outlook is improving, with the likelihood of
2022 policy rate rises having increased
 	At 1H21, NII sensitivity to a +100bps parallel
shift in yield curves would increase NII by
$5.8bn in year 1 and by $8.2bn in year 510
Discrete quarterly
reported NIM
Average interest
earning assets,
$bn
Reported NII, $m
of which:
significant items 6,584 	6,610
18
3Q21	3Q20
(48) 	1
4Q20 	1Q21 	2Q21
6,450 	6,619 	6,514
2,141 	2,208

-- 8 of 34 --

3Q21 results 	Appendix
(0.31) 	(0.45) 	0.17 	0.11
8
Credit performance
Adjusted ECL release/(charge) trend
 	3Q21 net ECL release of $0.7bn;
continued low Stage 3 charges, Stage 1–2
release of $1.0bn, reflecting continued
stability in economic and credit conditions
 	We retain approximately $1.2bn (31%)
of the $3.9bn Covid-19 related ECL uplift
on the balance sheet
 	Stage 3 loans and advances to customers
as a % of total loans is 1.8%, stable vs.
FY20
 	For FY21, expect a net release of ECL
charges, with a possible further small net
release in 4Q21, dependent on offsetting
levels of Stage 3 charges
 	Expect ECL charges to normalise in
2H22; medium-term ECL guidance range
of 30bps to 40bps
ECL
release/(charge)
as a % of
average
gross loans and
advances
ECL release/(charge) by stage, $bn	ECL release/(charge) by geography, $m
1Q21
(823)
4Q20
(1,199)
3Q20
432 	280
2Q21
659
3Q21
ECL, $m
3Q21 	Stage 1-2 	Stage 3 	Total*
Wholesale 	0.6 	(0.1) 	0.5
Personal 	0.4 	(0.1) 	0.3
Total 	1.0 	(0.2) 	0.7
0.25
3Q21 	2Q21
Hong Kong 	(37) 	(6)
Asia ex. Hong Kong 	(68) 	(168)
UK RFB 	563 	279
HSBC Bank plc 	95 	51
Mexico 	(12) 	(33)
Other 	118 	157
Total 	659 	280
* Total includes an additional $0.1bn ECL charge attributed to other assets, which are not staged

-- 9 of 34 --

3Q21 results 	Appendix
9
Adjusted costs
263
340
Marketing,
T&E
7,612
3Q20 	Cost
saves
(629)
30 	(31)
PRP 	Other
items incl.
investment
Tech
spend13
7,585
3Q21
(0)%
2Q21
7,936
(134)
Cost
saves
4
Marketing,
T&E
7,585
(377)
PRP
37
Tech
spend13
119
Other
items incl.
investment
3Q21
(4)%
Operating expenses trend, $m
6,277 	6,953 	6,586 	6,482 	6,124
1,335 1,444 	1,564 	1,454 	1,461
9,199
3Q21	3Q20
7,612
4Q20
802 	8,150
2Q21	1Q21
7,936 	7,585
UK bank levy 	Technology 11 	Other Group costs
3Q21 vs. 3Q20, $m	3Q21 vs. 2Q21, $m
 3Q21 costs of $7.6bn stable vs. 3Q20, with higher technology spend and
investment, offset by cost saves of $0.6bn; 3Q21 cost saves had associated
CTA of $0.4bn
 3Q21 costs were down $0.4bn (4%) vs. 2Q21, primarily due to a lower
performance-related pay (PRP) accrual and cost saves
 Programme saves to date of $2.6bn and associated CTA spend of $3.1bn
 Continue to expect total programme CTA spend of $7bn by FY22
 We now expect FY21 and FY22 adjusted costs to be broadly stable vs. FY20
at c.$32bn12 excluding the bank levy, due to inflationary and performance-
related pay pressure, investment and timing differences on acquisition and
disposals in FY22

-- 10 of 34 --

3Q21 results 	Appendix
10
Capital adequacy
3Q20 	4Q20 	1Q21 	2Q21 	3Q21
Common equity tier 1 capital, $bn 	133.4 	136.1 	134.5 	134.6 	133.2
Reported risk-weighted assets, $bn 	857.0 	857.5 	846.8 	862.3 	839.2
CET1 ratio, % 	15.6 	15.9 	15.9 	15.6 	15.9
Leverage ratio exposure, $bn 	2,857.4 	2,897.1 	2,930.2 	2,968.5 	2,964.8
Leverage ratio 1, % 	5.4 	5.5 	5.4 	5.3 	5.2
Capital progression
 CET1 ratio of 15.9%, up 0.3ppt vs. 2Q21
 Includes 3Q21 regulatory dividend accrual14
of $1.7bn (YTD $3.8bn) net of payment of 7¢
interim dividend
 Excludes c.25bps impact of announced
share buyback expected in 4Q21
 Reported RWAs of $839bn, down $23bn
vs. 2Q21, primarily due to reductions in short-
term IPO lending and FX movements
 Cumulative RWA saves of $93bn15, vs. FY22
target of $110bn
 Expect c.2% RWA inflation in 4Q21 from
growth and regulatory impacts; $20bn-$35bn
in FY22 from regulatory impacts
 Expected regulatory impacts on CET1 ratio
include c.25bps each from: Reversal of
software capitalisation benefit in 1Q22; France
loss on disposal in 2Q22
 Expect to be within target range of 14–14.5%
CET1 ratio by FY22, primarily via growth and
capital return
CET1 ratio, %
0.4
0.3
2Q21 	Profits 	Change
in RWAs
(0.0)
FX translation
differences
(0.2)
Other
15.9	(0.2)
Dividend
accrual 14
3Q21
15.6
134.6
862.3
133.2	CET1, $bn
RWAs, $bn 	839.2
(1.7) 	(1.2)
(14.4) 	(8.7)
3.2 	(1.7)

-- 11 of 34 --

3Q21 results 	Appendix
Summary
11
1
More positive revenue outlook; growth in mortgages, trade and deposit balances
— 	Stabilisation of NII
— 	Strong fee growth
2 Continued strong cost control; seeing some inflation and performance related pay
pressures. Expect c.$32bn costs for FY21 and FY2212, excluding the UK bank levy
4 Strong capital position, well placed to invest, grow and return capital to shareholders;
$2bn share buyback announced
* Illustrative impacts of IFRS 17 on our Insurance manufacturing business are detailed in the appendix
3 Interest rate outlook is constructive for returns; FY23 results onwards impacted by IFRS 17 * ,
remain committed to achieving a RoTE ≥10% over the medium-term16

-- 12 of 34 --

Appendix

-- 13 of 34 --

3Q21 results 	Appendix
13
Mainland China drawn risk exposure, at 30 June 2021
Mainland China drawn risk exposure17
183
1
10
43 46 51
2Q21	4Q19 4Q20
48
57 	57
2Q21	4Q19 4Q20
Reported loans and
advances to customers
Reported customer
deposits
 Mainland China drawn risk exposure (including Sovereigns, Banks and Customers) of $194bn comprising: Wholesale $183bn (of
which 53% is onshore); Retail: $11bn. These amounts exclude Markets financing
 Gross loans and advances to customers of $51bn in mainland China (Wholesale: $40bn; Retail $11bn)
 At 2Q21 Stage 3 loan balances and change in ECL remained low
 HSBC is selective in its lending. HSBC’s onshore corporate lending market share is 0.14% as at 2Q2118
Wholesale lending analysis17, $bn
Consumer Goods
& Retail
34.7
11.9 19.6
Other Sectors
Real Estate 19
Construction,
Materials & Engineering
9.8
IT & Electronics
5.6
Public Utilities 4.8
Metals & Mining
4.7
Transportation 4.4
3.7
Pharma &
Healthcare
Corporate lending by sector*
Wholesale lending by risk type:
CRRs 	1-3 	4-6 	7-8 	9+ 	Total
Sovereigns 	47.1 	0.0 	47.2
Banks 	32.7 	0.2 	32.9
NBFI 	2.9 	0.6 	3.5
Corporates 	65.4 	33.2 	0.1 	0.6 	99.3
Total 	148.1 	34.1 	0.1 	0.6 	182.8
85 	88 	99
37 	44 47
38 	33 33
167
2
2Q19
4
3
163
2Q20 	2Q21
183
NBFI
Banks
Sovereigns
Corporates
$ 194 bn
$ 99 bn
Credit cards
and other
consumer
Wholesale
Mortgages
* The corporate lending by sector has been corrected from the version published on 02 August 2021. The 2Q21 $99bn Corporate lending balances includes a $3.5bn increase following an exposure classification adjustment. Prior period balances
have not been restated
 c.18% of lending is to Foreign Owned Enterprises, c.39% of lending is
to State Owned Enterprises, c.44% to Private sector owned
Enterprises
Corporate real estate19:
 66% sits within CRR 1-3 (broadly equivalent to investment grade)
 Highly selective, focusing on top tier developers with strong
performance track records
 Focused on Tier 1 and selected Tier 2 cities
$bn
$bn 	$bn

-- 14 of 34 --

3Q21 results 	Appendix
14
Mainland China incorporated Property company exposure
Exposures to mainland China ultimate parent companies by
booking location, $bn
$bn
Exposure to mainland China ultimate parent companies 	14.7
Booked in mainland China 	4.2
Booked elsewhere 	10.5
- Of which: booked in Hong Kong	
10.0
- Of which: booked in rest of Asia-Pacific	
0.1
- Of which: booked in rest of world	
0.4
0.4
10.0
0.1
4.2
Rest of world	Hong Kong 	Other Asia	Mainland China
$14.7bn
At 30 June 2021
 Mainland China Real Estate exposures of $14.7bn do not include Hong
Kong incorporated property company exposures of $4.9bn which have
been booked in mainland China, but are a component of the $19.6bn of Real
Estate exposure on the previous slide
 Real Estate business to mainland China is highly selective; focused on
top tier developers with project lending concentrated in Tier 1 cities and
Tier 2 cities. At 30 June 2021:
 63% of exposure is to counterparties whose core business activity
focuses on Residential Real Estate Development
 66% of the book is categorised as investment grade, with 94% of
exposures broadly equivalent to an external credit rating of BB- or above
 As at 30 September 2021, HSBC has no direct credit exposure to
developers in the ‘Red’ category under the 3 red lines framework
introduced to the sector
 We continue to monitor the potential second order impacts of recent
developments
Mainland China Real Estate exposures19

-- 15 of 34 --

3Q21 results 	Appendix
15
Key financial metrics
Reported results, $m 	3Q21 	2Q21 	3Q20
NII 	6,610 	6,584 	6,450
Other Income 	5,402 	5,981 	5,477
Revenue 	12,012 	12,565 	11,927
ECL 	659 	284 	(785)
Costs 	(7,989) 	(8,560) 	(8,041)
Associates 	721 	771 	(27)
Profit before tax 	5,403 	5,060 	3,074
Tax 	(1,161) 	(1,206) 	(1,035)
Profit after tax 	4,242 	3,854 	2,039
Profit attributable to ordinary shareholders 	3,543 	3,396 	1,359
Profit attributable to ordinary shareholders excl.
goodwill and other intangible impairment and PVIF 3,492 	3,352 	1,109
Basic earnings per share, $ 	0.18 	0.17 	0.07
Diluted earnings per share, $ 	0.17 	0.17 	0.07
Dividend per share (in respect of the period), $ 	— 	0.07 	—
Return on avg. tangible equity (annualised), % 	8.7 	8.6 	2.9
Return on avg. equity (annualised), % 	8.0 	7.8 	3.2
Net interest margin (annualised), % 	1.19 	1.20 	1.20
Adjusted results, $m 	3Q21 	2Q21 	3Q20
NII 	6,610 	6,518 	6,646
Other Income 	5,591 	5,877 	5,728
Revenue 	12,201 	12,395 	12,374
ECL 	659 	280 	(823)
Costs 	(7,585) 	(7,936) 	(7,612)
Associates 	721 	769 	459
Profit before tax 	5,996 	5,508 	4,398
Cost efficiency ratio, % 	62.2 	64.0 	61.5
ECL charge/(release) as a % of average gross loans
and advances to customers (annualised) (0.25) 	(0.11) 	0.31
Balance sheet, $m 	3Q21 	2Q21 	3Q20
Total assets 	2,968,791 	2,976,005 	2,955,935
Net loans and advances to customers 	1,039,677 	1,059,511 	1,041,340
Adjusted net loans and advances to customers 	1,039,677 	1,045,360 	1,058,541
Customer accounts 	1,687,982 	1,669,091 	1,568,714
Adjusted customer accounts 	1,687,982 	1,647,240 	1,592,284
Quarterly average interest-earning assets 	2,207,960 	2,198,953 	2,141,454
Reported loans and advances to customers as % of customer
accounts 61.6 	63.5 	66.4
Total shareholders’ equity 	198,144 	198,218 	191,904
Tangible ordinary shareholders’ equity 	157,711 	157,985 	152,260
Net asset value per ordinary share at period end, $ 	8.70 	8.69 	8.41
Tangible net asset value per ordinary share at period end, $ 	7.81 	7.81 	7.55
Capital, leverage and liquidity 	3Q21 	2Q21 	3Q20
Reported risk-weighted assets, $bn 	839.2 	862.3 	857.0
CET1 ratio, % 	15.9 	15.6 	15.6
Total capital ratio (transitional), % 	21.3 	21.0 	21.2
Leverage ratio, % 	5.2 	5.3 	5.4
High-quality liquid assets (liquidity value), $bn 	664 	659 	654
Liquidity coverage ratio, % 	135 	134 	147
Share count, m 	3Q21 	2Q21 	3Q20
Basic number of ordinary shares outstanding 	20,201 	20,223 	20,173
Basic number of ordinary shares outstanding and dilutive
potential ordinary shares 20,296 	20,315 	20,227
Quarterly average basic number of ordinary shares
outstanding 20,213 	20,227 	20,166

-- 16 of 34 --

3Q21 results 	Appendix
16
Reconciliation of reported and adjusted PBT
$m 	3Q21 	2Q21 	3Q20
Reported PBT 	5,403 	5,060 	3,074
Revenue
Currency translation 	— 	(130) 	303
Customer redress programmes 	— 	— 	48
Fair value movements on financial instruments 	64 	(45) 	(11)
Restructuring and other related costs* 	125 	4 	101
Currency translation of significant items 	— 	1 	6
189 	(170) 	447
ECL
Currency translation 	— 	(4) 	(38)
Operating expenses
Currency translation 	— 	89 	(210)
Customer redress programmes 	7 	27 	3
Impairment of goodwill and other intangibles 	— 	— 	57
Restructuring and other related costs 	397 	514 	567
o/w: costs to achieve	
390	
499	
557
Settlements and provisions in connection with legal and regulatory matters 	— 	— 	3
Currency translation of significant items 	— 	(6) 	9
404 	624 	429
Share of profit in associates and joint ventures
Currency translation 	— 	(2) 	24
Impairment of goodwill 	— 	— 	462
— 	(2) 	486
Total currency translation and significant items 	593 	448 	1,324
Adjusted PBT 	5,996 	5,508 	4,398
Memo: tax on significant items (at reported FX rates) 	(71) 	(77) 	(162)
* Primarily comprises losses associated with RWA reduction commitments

-- 17 of 34 --

3Q21 results 	Appendix
17
Certain items included in adjusted revenue
Certain items included in adjusted revenue highlighted
in management commentary, $m 3Q21 	2Q21 	1Q21 	4Q20 	3Q20
Insurance manufacturing market impacts in WPB 	(40) 	334 	75 	298 	127
of which: Asia WPB insurance manufacturing market impacts	
(52)	
271	
(81)	
249	
156
Credit and funding valuation adjustments in GBM 	(49) 	3 	32 	72 	35
Legacy Credit in Corporate Centre 	(35) 	6 	9 	3 	28
Valuation differences on long-term debt and associated swaps
in Corporate Centre (35) 	(27) 	(28) 	(12) 	(32)
Argentina hyperinflation20 * 	(24) 	(42) 	(46) 	(42) 	(31)
Bid-offer adjustment in GBM* 	30 	35 	18 	7 	35
Total 	(153) 	309 	60 	326 	162
* Comparative figures have not been retranslated for foreign exchange movements

-- 18 of 34 --

3Q21 results 	Appendix
(3)%
284
1,760
3,098
2,061
3Q20
3,089
2,293
223
4Q20
255
3,038
1Q21
3,062
171
2,088
2Q21
185
3,067
2,206
3Q21
(40)	75	127 	298 	334
3Q21 financial highlights
Revenue 	$5.4bn (3)%
(3Q20: $5.6bn)
ECL 	$0.2bn >100%
(3Q20: $(0.4)bn)
Costs 	$(3.8)bn 0%
(3Q20: $(3.8)bn)
PBT 	$1.9bn 32%
(3Q20: $1.4bn)
RoTE21 	17.2% 9.6ppt
(9M20: 7.6%)
18
Wealth and Personal Banking
Revenue performance, $m
Wealth excl. market impacts 	Other
Personal banking
Balance sheet, $bn
Reported Wealth Balances4, $bn
468
3Q21	2Q21	3Q20
484
804 	831
482
845
3%
5%
Customer
lending
Customer
accounts
3Q21 vs. 3Q20
 Revenue down $152m (3%) driven by adverse insurance market
impacts of $167m, lower Markets Treasury revenue and lower
interest rates, offset by higher Wealth (excl. market impacts) revenue
 ECL net release of $237m vs. $370m charge in 3Q20, as economic
outlooks continued to improve resulting in Stage 1-2 releases
 Costs stable, with cost saves funding Asia Wealth investment and
offsetting higher costs related to increasing business volumes
 Customer lending up $14bn (3%), mainly mortgages ($23bn, net of
$3bn US HFS reclassification) and Lombard lending ($2bn), partially
offset by a reduction of short-term IPO loans in HK in 3Q20 ($11bn)
 Customer accounts up $41bn (5%) across most markets,
particularly in the UK ($31bn), partially offset by reclassification of
customer accounts to liabilities held for sale in the US ($10bn)
 Wealth balances up $150bn (10%). Growth across all segments,
particularly GPB client assets and Retail Wealth, driven by inflows
and higher market levels
3Q21 vs. 2Q21
 Revenue down $237m (4%) driven by adverse insurance market
impacts of $374m and lower interest rates, offset by higher Wealth
(excl. market impacts) revenue
 ECL net release of $237m vs. $32m release in 2Q21, as economic
outlooks continued to improve resulting in Stage 1-2 releases
 Costs stable, with cost saves funding investment in Asia Wealth
 Customer lending down $2bn (<1%), driven by a reduction in short-
term IPO loans in HK in 2Q21 ($9bn), largely offset by growth in
mortgages ($7bn)
 Customer accounts up $14bn (2%), driven by growth across most
markets, particularly in Private Banking ($6bn) and the UK ($4bn)Insurance manufacturing
market impacts
371
1,639
317
373
450
2Q21	3Q20
295
457
427
470
418
437
469
315
3Q21
1,489 1,671
10%
Global Private Banking
Client Assets
Retail Wealth Balances
Premier and Jade deposits
Asset Management
third party distribution
5,570 	5,370 	5,661 	5,655 	5,418

-- 19 of 34 --

3Q21 results 	Appendix
11%
(1)%
19
Commercial Banking
Balance sheet, $bn
943
436 	500
386
1,482
3Q20
371
426
4Q20
857
543
452
458
1,459
1Q21
459
474
1,479
870
2Q21
1,520
896
3Q21
908
1,481
3,247 	3,186 	3,311 	3,282 	3,374
4% 	3%
Markets products, Insurance
and Investments and Other
GTRF 	GLCM
Credit and Lending
3Q20 	2Q21 	3Q21
349 	347 	345
(0)%
3Q20 	2Q21 	3Q21
439 479 	488
2%
Customer lending
Customer accounts
3Q21 financial highlights
Revenue 	$3.4bn 4%
(3Q20: $3.2bn)
ECL 	$0.3bn >100%
(3Q20: $(0.4)bn)
Costs 	$(1.7)bn 0%
(3Q20: $(1.7)bn)
PBT 	$2.0bn 64%
(3Q20: $1.2bn)
RoTE21 	11.6% 10.5ppt
(9M20: 1.1%)
Revenue performance, $m
3Q21 vs. 3Q20
 Revenue up $127m (4%), the first YoY increase since the start of the
pandemic, driven by higher fees across all products, growth in trade
and deposit balances, notably in Asia, partially offset by the impact of
lower rates
 ECL release of $272m vs. charge of $363m in 3Q20 due to release of
Stage 1-2 provisions and limited Stage 3 charges
 Costs stable, driven by disciplined hiring and transformation saves
more than offsetting our investment in technology
 Customer lending down $4bn (1%), as 2021 growth, notably in
Asia, was more than offset by 4Q20 reductions reflecting the impact
of Covid-19
 Customer accounts up $50bn (11%), as customers raised and
retained liquidity, notably in Asia and Europe
3Q21 vs. 2Q21
 Revenue up $92m (3%), driven by growth across core products in
interest income and fees across all regions, notably in Asia and the
UK
 ECL release higher by $254m due to higher release of Stage 1-2
provisions and limited Stage 3 charges
 Costs down $77m (4%) as 2Q included higher performance-related
pay, continued disciplined hiring more than offset investment spend
 Customer lending down $1bn with continued growth in trade (up
$2bn) offset by repayments, notably $2bn of short term IPO loans in
Asia and US corporate real estate of $1bn
 Customer accounts up $9bn (2%), reflecting continued liquidity in
the market, notably in Asia and Europe

-- 20 of 34 --

3Q21 results 	Appendix
3Q21 financial highlights
Revenue 	$3.6bn (3)%
(3Q20: $3.7bn)
ECL 	$0.1bn >100%
(3Q20: $(0.1)bn)
Costs 	$(2.3)bn 1%
(3Q20: $(2.4)bn)
PBT 	$1.4bn 13%
(3Q20: $1.2bn)
RoTE21 	10.1% 3.2ppt
(9M20: 6.9%)
20
Global Banking and Markets
View of adjusted revenue
2Q21	3Q20 	3Q21
249	269 	253
(7)% 	(2)%
Adjusted RWAs22, $bn
3,537
(40)
1,626
4Q20
1,927
1Q21
2,066
17
3Q20
35
1,575
2,473
1,617
168
1,921
1,646
3,604
(23)
2Q21
1,985
1,659
4,258
3,709
3Q21
3,544
2%
MSS 	Other	Banking
Revenue performance, $m
$m 	3Q21 ∆3Q20
MSS 	1,985 	(4)%
Securities Services 	528 	27 %
Global Debt Markets 	164 	(46)%
Global FX 	772 	(8)%
Equities 	348 	49 %
Securities Financing 	222 	(5)%
XVAs 	(49) >(100)%
Banking 	1,659 	2 %
GTRF 	180 	2 %
GLCM 	465 	1 %
Credit & Lending 	629 	(8)%
Capital Markets &
Advisory 337 	18 %
Other 	48 	>100%
GBM Other 	(40) >(100)%
Principal Investments 	88 	66 %
Other 	(128) >(100)%
Net operating income 	3,604 	(3)%
3Q21 vs. 3Q20
 Revenue down $0.1bn (3%):
• 	Continued momentum in Equities, driven by wealth specifically in
Asia and Europe and by strong primary activity, with continued
volatility in Hong Kong and Shanghai stock exchanges
• 	Strong quarter for Securities Services as fees increased and we
grew Assets Under Custody by 23%
• 	Strong performance in Leveraged and Acquisition Finance reflecting
investment and strong activity, particularly in the US
• 	GLCM grew fees reflecting payment volume growth, higher card
spend and relative economic recovery
• 	Global Debt Markets performance was impacted by higher flow
activity in the prior year particularly in G10 derivatives, while 3Q21
was also impacted by lower capital employed for G10 derivatives
• 	Banking Credit & Lending revenue and balances lower primarily due
to strategic RWA actions
 ECL was a net release of $147m, reflecting Stage 1-2 releases due to
improved economic outlook compared to a $103m charge in 3Q20
 Costs down $23m (1%), primarily driven by cost saving initiatives
which more than offset higher technology investment and
performance-related pay accrual
3Q21 vs. 2Q21
 Revenue higher by $60m (2%):
• 	MSS up by 3% vs. prior quarter, primarily due to Securities
Services and Equities, with lower Global Debt Markets
• 	Good performance in M&A and US Leveraged and Acquisition
Finance, partly offset by seasonal reduction in DCM client activity
 ECL net release of $147m, vs. a higher net release of $224m in 2Q21

-- 21 of 34 --

3Q21 results 	Appendix
3Q21 financial highlights
Revenue 	$(195)m (28)%
(3Q20: $(152)m)
ECL 	$3m (77)%
(3Q20: $13m)
Costs 	$191m (3)%
(3Q20: $196m)
Associates 	$708m 58%
(3Q20: $449m)
PBT 	$707m 40%
(3Q20: $506m)
RoTE21 	5.4% 0.8ppt
(9M20: 4.6%)
21
Corporate Centre
Revenue performance, $m
4Q20
8
703
78
48
363 477
3Q20
150
767
675 136
38
1Q21
19
102
646
2Q21
103
66
539
3Q21
449
877
708
(8)%
Associate income detail, $m
3Q20 	4Q20 	1Q21 	2Q21 	3Q21
Central Treasury 	(32) 	(12) 	(28) 	(27) 	(35)
Legacy Credit 	28 	3 	9 	6 	(35)
Other 	(148) 	(138) 	(21) 	(65) 	(125)
Of which: FX revaluation on Holdings balance
sheet and net investment hedge
(26)	
(4)	
10	
(1)	
(11)
Total 	(152) 	(147) 	(40) 	(86) 	(195)
Not included in Corporate Centre revenue: Markets
Treasury revenue allocated to global businesses 672 	603 	798 	510 	524
Bank of Communications 	SABB 	Others
3Q21 vs. 2Q21
 Revenue down $109m, primarily due to a loss on disposal of legacy
portfolios in the US in 3Q21 and a one-off litigation cost in 3Q21
related to the sale of operations in Latin America
 Associates down $59m (8%), primarily due to lower share of profits
from BoCom and SABB
3Q21 vs. 3Q20
 Revenue down $43m, primarily due to a loss on disposal of legacy
portfolios in the US in 3Q21, against favourable funding fair value
adjustments in 3Q20
 Associates up substantially ($259m, 58%), primarily due to higher
share of profits from BoCom and BGF
Adjusted RWAs22, $bn
53
3Q20
50
3735
53
2Q21
33
3Q21
86	85 90
2% 	(4)%
Associates 	Other

-- 22 of 34 --

3Q21 results 	Appendix
22
Net interest margin supporting information
3Q20 	4Q20 	1Q21 	2Q21 	3Q21 % of 3Q21
Group NII
% of 3Q21
Group AIEA
The Hongkong and
Shanghai Banking
Corporation (HBAP)
1.44% 	1.42% 	1.40% 	1.37% 	1.35% 	48% 	42%
HSBC Bank plc
(NRFB) 0.50% 	0.53% 	0.51% 	0.48% 	0.47% 	9% 	22%
HSBC UK Bank plc
(UK RFB) 1.60% 	1.60% 	1.59% 	1.56% 	1.51% 	24% 	19%
HSBC North
America Holdings,
Inc
0.83% 	0.95% 	0.96% 	0.97% 	0.90% 	7% 	9%
Quarterly NIM by key legal entity
Key rates (quarter averages), basis points
34
27
14
9 	7 	6
9 	9 	8 	7 9 	8	10 	10 	10 	10 	10 	10
3Q20 	4Q20 	1Q21 	3Q21	2Q21 	4Q21 QTD*
BoE Base Rate
1M HIBOR
Fed effective rate
Source: Bloomberg	* At 22 October 2021
NII sensitivity to instantaneous change in yield curves (12 months)
Change in Jul
2021 to Jun 2022
Currency
USD 	HKD 	GBP 	EUR 	Other 	Total
$m 	$m 	$m 	$m 	$m 	$m
+25bps parallel 	114 	340 	561 	113 	374 	1,502
-25bps parallel 	(122) 	(393) 	(616) 	(83) 	(391) 	(1,605)
+100bps parallel 	369 	1,354 	2,053 	532 	1,464 	5,772
-100bps parallel 	(224) 	(837) 	(2,257) 	(330) 	(1,542) 	(5,190)
NII sensitivity to instantaneous change in yield curves (5 years), $m
Change in Jul
2021 to Jun 2026 Year 1 	Year 2 	Year 3 	Year 4 	Year 5 	Total
+25bps parallel 	1,502 	1,806 	1,976 	2,098 	2,158 	9,540
-25bps parallel 	(1,605) 	(2,085) 	(2,042) 	(2,152) 	(2,235) 	(10,119)
+100bps parallel 	5,772 	7,118 	7,778 	8,092 	8,179 	36,939
-100bps parallel 	(5,190) 	(6,924) 	(8,249) 	(8,892) 	(9,243) 	(38,498)
At 30 June 2021
At 30 June 2021

-- 23 of 34 --

3Q21 results 	Appendix
23
3Q21 vs. 2Q21 equity drivers
Shareholders’
Equity, $bn
Tangible Equity23,
$bn
TNAV per share,
$
Basic number of ordinary
shares, million
As at 30 June 2021 	198.2 	158.0 	7.81 	20,223
Profit attributable to: 	4.0 	3.8 	0.19 	—
Ordinary shareholders	
3.5	
3.8	
0.19 	—
Other equity holders	
0.5 	— 	— 	—
Dividends 	(1.9) 	(1.4) 	(0.07) 	—
On ordinary shares	
(1.4)	
(1.4)	
(0.07) 	—
On other equity instruments	
(0.5) 	— 	— 	—
FX 	(2.0) 	(1.8) 	(0.09) 	—
Actuarial gains/(losses) on defined benefit plans 	(0.0) 	(0.0) 	— 	—
Fair value movements through ‘Other Comprehensive Income’ 	(0.2) 	(0.2) 	(0.01) 	—
Of which: changes in fair value arising from changes in own credit risk	
0.2	
0.2	
0.01 	—
Of which: Debt and Equity instruments at fair value through OCI	
(0.4)	
(0.4)	
(0.02) 	—
Other 	0.0 	(0.7) 	(0.02) 	(22)
As at 30 September 2021 	198.1 	157.7 	7.81 	20,201
 Average basic number of shares outstanding during 3Q21: 20,213 million
 3Q21 TNAV per share of $7.81 stable vs. 2Q21, mainly due to profits of 19¢ offset by adverse FX
movements and dividends paid in the quarter
$7.77 on a fully diluted
basis
20,296 million on a
fully diluted basis

-- 24 of 34 --

3Q21 results 	Appendix
3Q20 	2Q21 	3Q21
(2)%
24
Balance sheet – customer lending
347
468
1
349
240 	214
1
484 	482
345
212
1
1,059 	1,045 	1,040
(1)%
Balances by global business, $bn
WPB 	CMB 	GBM 	Corporate Centre
Adjusted customer lending of
$1,040bn down $6bn (1%) vs.
2Q21; primarily due to the repayment
of $14bn of short-term IPO loans in
Hong Kong
 WPB lending of $482bn
decreased $2bn (<1%), $9bn of
IPO lending repayments were partly
offset by $7bn of mortgage growth,
primarily in the UK and Hong Kong
 CMB lending of $345bn down
$1bn (1%) with growth in trade (up
$2bn) offset by repayments, notably
$2bn of short term IPO loans in Asia
and US CRE of $1bn
Balances by region, $bn
Europe
Asia
MENA
North
America
o/w: US
Total
o/w: Hong
Kong
o/w: UK
Latin
America
$(15)bn
(5)%
$(12)bn
(2)%
2
2
$5bn
1%
$(0)bn
(1)%
$5bn
2%
$(0)bn
(2)%
$1bn
1%
$1bn
3%
$(6)bn
(1)%
Growth since 2Q21
o/w: mortgages
o/w: mortgages
$398bn
$488bn
$27bn
$106bn
$20bn
$1,040bn
$311bn
$313bn
$52bn

-- 25 of 34 --

3Q21 results 	Appendix
6%
3Q21
439
804
3Q20
349
479
1
831
2Q21
336
1
354
845
1
488
1,592 1,647 1,688
2%
25
Balance sheet – customer accounts
Balances by global business, $bn
Adjusted customer accounts of
$1,688bn, up $41bn (2%) vs. 2Q21
 WPB customer accounts of
$845bn increased $14bn (2%),
with broad-based growth across
markets
 Wholesale customer accounts
of $842bn increased $27bn (3%)
as clients continue to build and
retain liquidity
WPB 	CMB 	Corporate centre	GBM
Balances by region, $bn
Europe
Asia
MENA
North
America
o/w: US
Total
o/w: Hong
Kong
o/w: UK
Latin
America
$19bn
3%
$4bn
2%
$12bn
2%
$3bn
3%
$9bn
2%
$15bn
2%
$1bn
3%
$41bn
2%
$1bn
5%
Growth since 2Q21
$667bn
$771bn
$42bn
$179bn
$28bn
$1,688bn
$533bn
$537bn
$114bn

-- 26 of 34 --

3Q21 results 	Appendix
26
IFRS 1724 - Summary
IFRS 17 ‘Insurance Contracts’
 IFRS 17 is effective from 1 January 2023 and will result in a number
of changes compared to our current accounting policies
 No PVIF asset is recognised, rather the estimated future profit will be
included in the measurement of the insurance contract liability as the
contractual service margin (‘CSM’) and gradually recognised in
revenue as services are provided over the duration of the
insurance contract
 While the profit over the life of an individual contract will be unchanged,
its emergence will be later under IFRS 17
 Directly attributable costs will be incorporated in the CSM which will
result in a reduction in reported operating expenses
 Our initial assumption (based on analysis of the expected 2022 position)
is that the resultant accounting changes may result in a step down in
the profitability of our insurance business by approximately two
thirds on the transition, albeit with a range of expected outcomes.
The RoE of the insurance business is not expected to be
significantly impacted
 A similar impact is expected on the equity of the insurance business,
primarily reflecting the elimination of the PVIF asset of $9.4bn, with an
associated deferred tax liability of $1.7bn as at 1H21 and the creation of
a CSM liability (the latter impacting tangible equity)
 No significant effects on the distribution of dividends from insurance
subsidiaries nor on the bank’s regulatory capital are expected
 Insurance remains a core part of HSBC’s Wealth strategy. Continued
growth in new business sales will support ongoing earnings growth from
the new baseline after transition to IFRS 17
Insurance manufacturing
Reported income statement, $m 	FY18 	FY19 	FY20 	1H21
Revenue 	2,040 	2,711 	1,977 	1,555
Of which: VNB 	1,117 	1,225 	776 	563
Of which: market impacts 	(326) 	124 	102 	413
Operating expenses 	(491) 	(505) 	(509) 	(280)
Profit before tax 	1,578 	2,135 	1,377 	1,262
 Items in table are non-additive
 VNB will no longer be recognised in the income statement under IFRS 17; instead revenue will
emerge over the life of the contracts written
 The current intention is that VNB, Embedded Value and other return and performance metrics
will continue to be provided as disclosures for comparability
Reported Embedded value, $bn
7.7
2019 	1H21
7.7
6.6
5.7
2018
7.7
2020
7.3
6.6 8.7
12.2 13.9 15.4 	16.4
Other net assets 	PVIF and related deferred tax 25

-- 27 of 34 --

3Q21 results 	Appendix
27
Insurance manufacturing reporting today
Insurance as part of HSBC Group
11%
89%
1H21 Group adjusted PBT, $bn
9%
91%
1H21 Group ordinary shareholders’ equity, $bn
Insurance
Rest of Group
Insurance
Rest of Group
$12.0bn
$175.8bn
 	Today HSBC reports Insurance Manufacturing results under IFRS 4:
 	Insurance liabilities reflect current local market practices and
regulatory approaches
 	Value of New Business (VNB), a measure that recognises the
expected profit to be earned over the lifetime of that business, is
reported upfront as revenue when a new policy is written
 	An intangible asset for the present value of in-force life
insurance business (PVIF) is created on the balance sheet as
permitted under the UK approach to bancassurance
 	VNB and PVIF are calculated based on future expected
investment return assumptions based on the assets held
 	PVIF is incorporated in ordinary shareholders’ equity, but
eliminated from tangible equity and CET1 calculations
Current accounting treatment
0.4
0.9
1H21
1.3
of which:
market impacts
1H21 Insurance PBT, $bn
7.7
1H21
16.4
8.7
1H21 reported Embedded value, $bn
PVIF and related
deferred tax
Other net assets

-- 28 of 34 --

3Q21 results 	Appendix
Total profit
recognised over
the lifetime of
the contract is
unchanged
28
Insurance manufacturing reporting under IFRS 17
Recognised profit over time
Directional expected impact on tangible equity on transition
IFRS 17
IFRS 4
End of contract	Year 1 	Time
Loss of Day 1 profit
recognition
PVIF
elimination
IFRS 4 equity 	Restating
assets
IFRS 4
tangible
equity
Restating
liabilities
CSM 	IFRS 17
tangible
equity
PVIF
Other net
assets
 HSBC will adopt IFRS 17 from 1 January 2023, with 2022 comparatives restated
 Equity at transition will be impacted by the following:
 Elimination of PVIF intangible and the related deferred tax liability
 Establishing a Contractual Service Margin (‘CSM’) liability representing the unearned margins
of the in-force business. It is calculated based on market consistent assumptions where
future investments spreads are excluded
 Reclassification of certain assets to fair value, matching updated IFRS 17 liability
measurement
 Revenue will no longer be booked up-front, but instead will be recognised as services
are provided over the life of the contracts written
 Earnings will predominantly be generated by the unwind of the CSM of the in-force business
and the emergence of asset spreads above the IFRS 17 discount rate
 Unlike current accounting where market impacts and changes in assumptions are reported
immediately in profit or loss, under IFRS 17 these are spread over the remaining life of the
impacted contracts
Directional expected profit impact on 2022 comparatives
IFRS 4
tangible
PBT
IFRS 4 PBT VNB and
other PVIF
movements
CSM
release
Experience
variance
Attributable
cost
impact26
Economic
impact
IFRS
17 PBT

-- 29 of 34 --

3Q21 results 	Appendix
29
IFRS 4 vs. IFRS 17 – Key differences
IFRS 4 	IFRS 17
Profit emergence /
recognition
 Value of new business (VNB) is reported as revenue on Day 1 	 Contractual service margin (CSM) will be reported as liability on Day 1
and recognised in revenue as services are provided (i.e. no Day 1 profit)
Investment return
assumptions
(discount rate)
 VNB is calculated based on long-term investment return assumptions
based on assets held. It therefore includes future investment margins
expected to be earned in future, unlike under IFRS 17
 CSM is calculated based on market consistent assumptions aligned with
the characteristics of the liability
 Under the market consistent approach, future ‘investment spreads’ (the
risk premia expected to be earned for taking equity risk, default risk, and
liquidity risk) are excluded from reported earnings until they are actually
earned in future time periods
Expenses 	 Total expenses to acquire and maintain the contract over its lifetime are
included in the VNB calculation
 Expenses are recognised across operating expenses and fee expense as
incurred, and the allowances for those costs released from the PVIF
simultaneously
 Projected lifetime expenses that are directly attributable to acquiring and
maintaining the portfolio of contracts are included in the CSM
calculation, and amortised over the life of the contract as a deduction
from Insurance Service revenue, not recognised as incurred
 Non-attributable costs are reported in operating expenses as incurred
Balance sheet 	 Assets mostly measured at amortised cost and fair value.
 Liabilities measured per local statutory/ regulatory requirements.
 An intangible asset for the present value of in-force life insurance
business (PVIF) is created
 CSM balance will be recognised as a liability
 Assets and liabilities will be measured at current value
 PVIF asset will no longer be recognised, and existing PVIF asset will be
eliminated to equity on transition
Impact on key
metrics
 Cost income ratio of HSBC may be impacted
 The combined impact of the changes in equity and profits will
not significantly impact Group RoE
 We intend to introduce a new suite of IFRS 17 KPIs to help facilitate peer
to peer comparisons

-- 30 of 34 --

3Q21 results 	Appendix
30
Glossary
AIEA 	Average interest earning assets
BGF 	Business Growth Fund, an associate of HSBC
BoCom 	Bank of Communications Co. Limited, an associate of HSBC
Bps 	Basis points. One basis point is equal to one-hundredth of a percentage point
CET1 	Common Equity Tier 1
Corporate Centre 	Corporate Centre comprises Central Treasury, our legacy businesses, interests in our associates and joint
ventures, central stewardship costs and the UK bank levy
CMB 	Commercial Banking, a global business
CRR 	Customer Risk Rating
CTA 	Costs to achieve
C&L 	Credit and Lending
DCM 	Debt Capital Markets
ECL
Expected credit losses. In the income statement, ECL is recorded as a change in expected credit losses
and other credit impairment charges. In the balance sheet, ECL is recorded as an allowance for financial
instruments to which only the impairment requirements in IFRS 9 are applied
GBM 	Global Banking and Markets, a global business
GLCM 	Global Liquidity and Cash Management
Group 	HSBC Holdings plc and its subsidiary undertakings
GTRF 	Global Trade and Receivables Finance
HIBOR 	Hong Kong Interbank Offered Rate
IFRS 	International Financial Reporting Standard
LCR 	Liquidity coverage ratio
Legacy credit 	A portfolio of assets including securities investment conduits, asset-backed securities, trading portfolios,
credit correlation portfolios and derivative transactions entered into directly with monoline insurers
MENA 	Middle East and North Africa
MSS 	Markets and Securities Services
NCI 	Non-controlling interests
NII 	Net interest income
NIM 	Net interest margin
NNM 	Net new money
NRFB 	Non ring-fenced bank in Europe and the UK
OCI 	Other Comprehensive Income
PBT 	Profit before tax
Ppt 	Percentage points
PVIF 	Present value of in-force insurance contracts
SABB 	The Saudi British Bank, an associate of HSBC
UK RFB 	HSBC UK, the UK ring-fenced bank, established July 2018 as part of ring fenced bank legislation
RoTE 	Return on average tangible equity
RWA 	Risk-weighted asset
TNAV 	Tangible net asset value
WPB 	Wealth and Personal Banking, a global business
XVAs 	Credit and Funding Valuation Adjustments

-- 31 of 34 --

3Q21 results 	Appendix
31
Footnotes
1. 	Unless otherwise stated, regulatory capital ratios and requirements are based on the transitional arrangements of the Capital Requirements Regulation in force at the time. These include the regulatory transitional arrangements for IFRS 9
‘Financial Instruments’. Following the end of the transition period after the UK’s withdrawal from the EU, any reference to EU regulations and directives (including technical standards) should be read as a reference to the UK’s version of such
regulation and/or directive, as onshored into UK law under the European Union (Withdrawal) Act 2018
2. 	RoTE methodology annualises Profits Attributable to Shareholders, including ECL, in order to provide a returns metric
3. 	WPB adjusted fees up $0.1bn (6%), CMB adjusted fees up $0.1bn (13%) and GBM adjusted fees up $0.1bn (11%)
4. 	Inclusive of Premier & Jade deposits and AUM, GPB client assets and AMG AUM
5. 	At 30 September 2021
6. 	Source: BoE. Stock mortgage market share at 30 August 2021. Gross market share is for August YTD
7. 	Source: HKMA at 31 August 2021; Hong Kong market share includes HASE
8. 	Source: MAS monthly statistical bulletin at 30 June 2021
9. 	Source: Dealogic, at 30 September 2021. Volume shows the full (non-apportioned) amount of financing raised in transactions in which HSBC led or co-led
10. Based on a static balance sheet at 30 June 2021
11. Technology costs in operating expenses trends include transformation saves and are presented on a net basis
12. Previous guidance for FY22 was $31.5bn including the bank levy on a constant currency basis at 30 June 2021 average FX rates
13. Technology cost increases in quarterly walks are presented on a gross basis (excl. saves)
14. Regulatory dividend accrual for the purposes of capital calculations. Over 9M21 we accrued 25.7¢, equal to 47.5% of reported EPS of 54¢, the mid-point of our 40%-55% targeted payout ratio range. In line with our dividend policy, we will retain
the flexibility to adjust EPS for non-cash significant items. Additionally, in 2022, we expect to exclude from EPS the forecast loss on the sale of our retail banking operations in France
15. Cumulative RWA saves under our transformation programme as measured from 1 January 2020 to 30 September 2021, including $9.6bn of accelerated saves made over 4Q19
16. Medium term defined as three to four years from 1 January 2020
17. Mainland China drawn risk exposure. Retail drawn exposures represent retail lending booked in mainland China; Wholesale lending where the exposure is booked in mainland China or the ultimate parent/beneficial owner is in mainland China
18. Source: People’s Bank of China Financial Statistics Report H1 2021
19. Mainland China reported Real Estate exposures of $19.6bn at 1H21 comprises exposures to mainland China parent Real Estate companies of $14.7bn as shown in the table on slide 14, and $4.9bn of exposures not included in the table, but
booked on mainland China entity balance sheets by corporates incorporated outside of mainland China (primarily Hong Kong incorporated companies); Real Estate is defined as lending to companies involved in Commercial Real Estate, Real
Estate for Self Use and Real Estate Management & Service companies; Commercial Real Estate refers to lending that focuses on commercial development and investment in real estate and covers commercial, residential and industrial assets;
Real Estate for Self Use refers to lending to a corporate or financial entity for the purchase or financing of a property which supports overall operations of a business i.e. a warehouse for an e-commerce firm
20. From 1st July 2018, Argentina was deemed a hyperinflationary economy for accounting purposes
21. YTD, annualised. RoTE by Global Business excludes significant items. RoTE methodology annualises Profits Attributable to Shareholders, including ECL, in order to provide a returns metric. RoTE by Global Business considers AT1 Coupons on an
accruals basis, vs. Reported RoTE where it is treated on a cash basis
22. Data to reconcile components of reported RWAs to adjusted RWAs can be found in the ‘HSBC Holdings plc 3Q 2021 Datapack’
23. Differences between shareholders’ equity and tangible equity drivers primarily reflect AT1 capital, goodwill and other intangibles and PVIF. ‘Profit Attributable to Ordinary shareholders’ differences primarily include goodwill and other intangibles
impairment, PVIF movements and amortisation expense. ‘FX’ differences primarily include FX on goodwill and intangibles. ‘Other’ differences primarily include intangible additions and redemption of securities
24. The information in this slide is based on HSBC's current expectation of the manner in which the IFRS 17 standard will be implemented, which may be subject to further changes, as HSBC is currently in the process of implementing IFRS 17 and
industry practice and interpretation of the standard are still developing. Additionally, the impact on the forecast future returns of HSBC's insurance business is dependent on the growth, duration and composition of its insurance contract
portfolio. Therefore, the likely numerical impact of its implementation remains uncertain
25. Gross PVIF as reported at 1H21 is $9.4bn, and deferred tax liabilities arising on recognition of PVIF is $1.7bn
26. Reported operating expenses will reduce as expenses directly attributable to insurance contracts will be reported as a deduction from Insurance service revenue

-- 32 of 34 --

3Q21 results 	Appendix
32
Disclaimer
Important notice
The information, statements and opinions set out in this presentation and accompanying discussion (“this Presentation”) are for informational and reference purposes only and do not constitute a public offer for the purposes of any applicable law or
an offer to sell or solicitation of any offer to purchase any securities or other financial instruments or any advice or recommendation in respect of such securities or other financial instruments.
This Presentation, which does not purport to be comprehensive nor render any form of legal, tax, investment, accounting, financial or other advice, has been provided by HSBC Holdings plc (together with its consolidated subsidiaries, the “Group”)
and has not been independently verified by any person. You should consult your own advisers as to legal, tax investment, accounting, financial or other related matters concerning any investment in any securities. No responsibility, liability or
obligation (whether in tort, contract or otherwise) is accepted by the Group or any member of the Group or any of their affiliates or any of its or their officers, employees, agents or advisers (each an “Identified Person”) as to or in relation to this
Presentation (including the accuracy, completeness or sufficiency thereof) or any other written or oral information made available or any errors contained therein or omissions therefrom, and any such liability is expressly disclaimed.
No representations or warranties, express or implied, are given by any Identified Person as to, and no reliance should be placed on, the accuracy or completeness of any information contained in this Presentation, any other written or oral information
provided in connection therewith or any data which such information generates. No Identified Person undertakes, or is under any obligation, to provide the recipient with access to any additional information, to update, revise or supplement this
Presentation or any additional information or to remedy any inaccuracies in or omissions from this Presentation. Past performance is not necessarily indicative of future results. Differences between past performance and actual results may be
material and adverse.
Forward-looking statements
This Presentation may contain projections, estimates, forecasts, targets, opinions, prospects, results, returns and forward-looking statements with respect to the financial condition, results of operations, capital position, strategy and business of the
Group which can be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “anticipate”, “project”, “plan”, “estimate”, “seek”, “intend”, “target”, “believe”, "potential" and "reasonably possible" or the
negatives thereof or other variations thereon or comparable terminology (together, “forward-looking statements”), including the strategic priorities and any financial, investment and capital targets and ESG target/commitments described herein. Any
such forward-looking statements are not a reliable indicator of future performance, as they may involve significant stated or implied assumptions and subjective judgements which may or may not prove to be correct. There can be no assurance that
any of the matters set out in forward-looking statements are attainable, will actually occur or will be realised or are complete or accurate. The assumptions and judgments may prove to be incorrect and involve known and unknown risks,
uncertainties, contingencies and other important factors, many of which are outside the control of the Group. Actual achievements, results, performance or other future events or conditions may differ materially from those stated, implied and/or
reflected in any forward-looking statements due to a variety of risks, uncertainties and other factors (including without limitation those which are referable to general market conditions, regulatory changes or due to the impact of the Covid-19
pandemic). Any such forward-looking statements are based on the beliefs, expectations and opinions of the Group at the date the statements are made, and the Group does not assume, and hereby disclaims, any obligation or duty to update, revise
or supplement them if circumstances or management’s beliefs, expectations or opinions should change. For these reasons, recipients should not place reliance on, and are cautioned about relying on, any forward-looking statements. No
representations or warranties, expressed or implied, are given by or on behalf of the Group as to the achievement or reasonableness of any projections, estimates, forecasts, targets, commitments, prospects or returns contained herein.
Additional detailed information concerning important factors that could cause actual results to differ materially from this Presentation is available in our Annual Report and Accounts for the fiscal year ended 31 December 2020 filed with the Securities
and Exchange Commission (the “SEC”) on Form 20-F on 24 February 2021 (the “2020 Form 20-F”), our 1Q 2021 Earnings Release furnished to the SEC on Form 6-K on 27 April 2021 (the “1Q 2021 Earnings Release”), our Interim Financial Report for
the six months ended 30 June 2021 furnished to the SEC on Form 6-K on 2 August 2021 (the “2021 Interim Report”) and our 3Q 2021 Earnings Release, which we expect to furnish to the SEC on Form 6-K on 25 October 2021 (the “3Q 2021 Earnings
Release”).
Alternative Performance Measures
This Presentation contains non-IFRS measures used by management internally that constitute alternative performance measures under European Securities and Markets Authority guidance and non-GAAP financial measures defined in and presented
in accordance with SEC rules and regulations (“Alternative Performance Measures”). The primary Alternative Performance Measures we use are presented on an “adjusted performance” basis which is computed by adjusting reported results for the
period-on-period effects of foreign currency translation differences and significant items which distort period-on-period comparisons. Significant items are those items which management and investors would ordinarily identify and consider
separately when assessing performance in order to better understand the underlying trends in the business.
Reconciliations between Alternative Performance Measures and the most directly comparable measures under IFRS are provided in our 2020 Form 20-F, our 1Q 2021 Earnings Release, our 2021 Interim Report and our 3Q 2021 Earnings Release,
when filed, each of which are available at www.hsbc.com.
Information in this Presentation was prepared as at 25 October 2021.

-- 33 of 34 --



-- 34 of 34 --